[1]
|
Smits, P.C., Frigoli, E., Tijssen, J., Jüni, P., et al. (2021) Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk with or without Oral Anticoagulant Therapy after Coronary Stenting: An Open-Label, Randomized, Controlled Trial. Circulation, 144, 1196-1211. https://doi.org/10.1161/CIRCULATIONAHA.121.056680
|
[2]
|
Locham, S., Beaulieu, R.J., Dakour-Aridi, H., et al. (2018) Role of Antiplatelet Therapy in the Durability of Hemodialysis Access. Journal of Nephrology, 31, 603-611. https://doi.org/10.1007/s40620-018-0490-6
|
[3]
|
Ramanan, B., Jeon-Slaughter, H., Chen, X., et al. (2021) Impact of Dual Antiplatelet Therapy after Lower Extremity Revascularization for Chronic Limb-Threatening Ischemia. Journal of Vascular Surgery, 74, 1327-1334.
https://doi.org/10.1016/j.jvs.2021.04.067
|
[4]
|
Kao, C.C., Wu, M.S., Chuang, M.T., et al. (2021) Investigation of Dual Antiplatelet Therapy after Coronary Stenting in Patients with Chronic Kidney Disease. PLOS ONE, 16, e0255645. https://doi.org/10.1371/journal.pone.0255645
|
[5]
|
Fleg, J.L., Aronow, W.S., Frishman, W.H. (2011) Cardiovascular Drug Therapy in the Elderly: Benefits and Challenges. Nature Reviews Cardiology, 8, 13-28. https://doi.org/10.1038/nrcardio.2010.162
|
[6]
|
Fernández-Baltar, C., Pérez-Fentes, D., Sánchez-García, J.F., et al. (2018) Safety of Percutaneous Nephrolithotomy in Patients on Chronic Anticoagulant or Antiplatelet Therapy. Urolithiasis, 46, 581-585.
https://doi.org/10.1007/s00240-018-1034-1
|
[7]
|
Sachdeva, A., Hung, Y.Y., Solomon, M.D., et al. (2020) Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Chronic Total Occlusion. American Journal of Cardiology, 132, 44-51.
https://doi.org/10.1016/j.amjcard.2020.06.066
|
[8]
|
Aspegren, O.P., Åstrand, R., Lundgren, M.I., et al. (2013) Anticoagulation Therapy a Risk Factor for the Development of Chronic Subdural Hematoma. Clinical Neurology and Neurosurgery, 115, 981-984.
https://doi.org/10.1016/j.clineuro.2012.10.008
|
[9]
|
Liedtke, J.P., Ahrens, I. (2021) Antiplatelet Therapy and Anticoagulation in Patients with Coronary Heart Disease. Deutsche Medizinische Wochenschrift, 146, 1041-1050. https://doi.org/10.1055/a-1241-6676
|
[10]
|
Nia, A.M., Srinivasan, V.M., Lall, R.R., et al. (2021) Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A National Database Study of 191 Patients in the United States. World Neurosurgery, 153, e300-e307.
https://doi.org/10.1016/j.wneu.2021.06.101
|
[11]
|
Manckoundia, P., Buzens, J.B., Mahmoudi, R., et al. (2017) The Prescription of Antiplatelet Medication in a Very Elderly Population: An Observational Study in 15,141 Ambulatory Subjects. International Journal of Clinical Practice, 71, e13020. https://doi.org/10.1111/ijcp.13020
|
[12]
|
Russell, J.B.W., Baryoh, M.L., Conteh, V., et al. (2021) Outcomes of Craniotomies for Chronic Subdural Hematoma in Sierra Leone. The Pan African Medical Journal, 38, Article 80. https://doi.org/10.11604/pamj.2021.38.80.19173
|
[13]
|
Liang, Y., Zou, C.H., et al. (2019) Research Progress of Medicinal Secondary Metabolites and Gene Cloning of Dendrobium officinale. Medicinal Plant, 10, 16-18, 23.
|
[14]
|
Iqbal, U., Dennis, B.B., Li, A.A., et al. (2019) Use of Anti-Platelet Agents in the Prevention of Hepatic Fibrosis in Patients at Risk for Chronic Liver Disease: A Systematic Review and Meta-Analysis. Hepatology International, 13, 84-90.
https://doi.org/10.1007/s12072-018-9918-2
|
[15]
|
Nickinson, A.T.O., Coles, B., Zaccardi, F., et al. (2020) Missed Opportunities for Timely Recognition of Chronic Limb Threatening Ischaemia in Patients Undergoing a Major Amputation: A Population Based Cohort Study Using the UK’s Clinical Practice Research Datalink. European Journal of Vascular and Endovascular Surgery, 60, 703-710.
https://doi.org/10.1016/j.ejvs.2020.05.010
|
[16]
|
Guidry, B.S., Kelly, K.A., Yengo-Kahn, A.M., et al. (2021) Statins as a Medical Adjunct in the Surgical Management of Chronic Subdural Hematomas. World Neurosurgery, 149, e281-e291. https://doi.org/10.1016/j.wneu.2021.02.036
|
[17]
|
韦宝敏, 潘兴寿, 李天资, 等. H型高血压患者MTHFR C677T基因多态性及其与血压、HCY水平的关系[J]. 检验医学与临床, 2021, 18(7): 889-892.
|
[18]
|
Motiei-Langroudi, R., Alterman, R.L., Stippler, M., et al. (2019) Factors Influencing the Presence of Hemiparesis in Chronic Subdural Hematoma. Journal of Neurosurgery, 131, 1926-1930. https://doi.org/10.3171/2018.8.JNS18579
|
[19]
|
Jelani, Q.U., Llanos-Chea, F., Bogra, P., et al. (2021) Guideline-Directed Medical Therapy in Patients with Chronic Kidney Disease Undergoing Peripheral Vascular Intervention. American Journal of Nephrology, 52, 845-853.
https://doi.org/10.1159/000519484
|
[20]
|
Hostettler, I.C., Seiffge, D., Wong, A., et al. (2022) APOE and Cerebral Small Vessel Disease Markers in Patients with Intracebral Hemorrhage. Neurology, 99, e1290-e1298. https://doi.org/10.1212/WNL.0000000000200851
|
[21]
|
Shao, A., Shi, J., Liang, Z., et al. (2022) Meta-Analysis of the Association between Apolipoprotein E Polymorphism and Risks of Myocardial Infarction. BMC Cardiovascular Disorders, 22, Article No. 126.
https://doi.org/10.1186/s12872-022-02566-0
|
[22]
|
陆荣臻, 黄江南, 潘兴寿, 等. 不同降压模式在老年高血压合并冠心病患者PCI术后的应用效果研究[J]. 天津医药, 2023, 51(3): 277-281.
|
[23]
|
Wada, M., Yamakami, I., Higuchi, Y., et al. (2014) Influence of Antiplatelet Therapy on Postoperative Recurrence of Chronic Subdural Hematoma: A Multicenter Retrospective Study in 719 Patients. Clinical Neurology and Neurosurgery, 120, 49-54. https://doi.org/10.1016/j.clineuro.2014.02.007
|
[24]
|
潘兴寿, 梁烨, 曾德创, 等. 野芭蕉多糖对自发性高血压大鼠血管平滑肌细胞增殖的影响及其与胆固醇调节元件结合蛋白表达的关系[J]. 中华中医药杂志, 2019, 34(7): 3026-3030.
|
[25]
|
Abdallah, G.E.M., Elbiih, E.A.S., Sayed, D., et al. (2021) Revisiting the Management of Chronic ITP; a Randomized Controlled Clinical Trial. Platelets, 32, 243-249. https://doi.org/10.1080/09537104.2020.1738367
|
[26]
|
言纬, 李近都. 前蛋白转化酶枯草溶菌素Kexin 9型及其与脂类物质代谢紊乱、动脉硬化性疾病关系的研究进展[J]. 广西医学, 2022, 44(24): 2909-2912.
|
[27]
|
Grinberg, T., Bental, T., Hammer, Y., et al. (2021) Management and Outcome across the Spectrum of High-Risk Patients with Myocardial Infarction According to the Thrmobolysis in Myocardial Infarction (TIMI) Risk-Score for Secondary Prevention. Clinical Cardiology, 44, 1535-1542. https://doi.org/10.1002/clc.23715
|
[28]
|
梁烨, 邹才华, 李近都, 等. 石斛药用次生代谢产物及其基因克隆研究进展[J]. 中华中医药杂志, 2018, 33(12): 5511-5514.
|
[29]
|
陆春雷, 潘兴寿, 黄春合, 等. 石斛辅助治疗HBeAg阳性慢性乙型肝炎疗效观察[J]. 时珍国医国药, 2014, 25(11): 2698-2700.
|
[30]
|
江洪, 梁烨, 李近都, 等. 野芭蕉通络汤治疗对高血压患者miR-375调控的临床观察[J]. 中药药理与临床, 2015, 31(2): 103-104.
|